Literature DB >> 7696350

The role of cyclic AMP in the lipopolysaccharide-induced suppression of thymidine kinase activity in macrophage.

F Okada1, S Nagao, Y Harada, R M Xavier, M Nakamura, T Ishida, Y Tanigawa.   

Abstract

We observed that lipopolysaccharide (LPS, 1 micrograms/ml) can suppress [3H]thymidine incorporation into acid-insoluble fraction in a mouse macrophage cell line J774 (over 70% at 6 h) without affecting the uptake of [3H]thymidine or DNA polymerase activity. Paralleling this suppression, a decrease in the thymidine kinase (TK) activity, but not of thymidine monophosphate (TMP) kinase and thymidine diphosphate (TDP) kinase, was observed. LPS dose-dependently increased intracellular cAMP levels to about 3.5-times basal at 6 h, proportionally to the decrease of the TK activity. Elevation of intracellular cAMP by several reagents also decreased TK activity. Apparently LPS treatment elevates cAMP concentration by decreasing the low Km cAMP phosphodiesterase activity (58% at 6 h). The time course of cAMP-dependent protein kinase (PK-A) activity during the first 6 h after LPS treatment correlated with that of cAMP concentration. Treatment with a PK-A inhibitor restored about 63% of LPS-induced reduction of TK activity at 6 h. At longer times, however, there was a discrepancy between the change of cAMP concentration or PK-A activity and the reduction of TK activity. Therefore, protein kinase activation caused by the accumulation of intracellular cAMP probably triggers some mechanism responsible for the reduction of the TK activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7696350     DOI: 10.1016/0167-4889(94)00228-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment.

Authors:  H Weidenbach; K Beckh; M Burger; T Schricker; M Georgieff; G Adler
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Cholecystokinin inhibits inducible nitric oxide synthase expression by lipopolysaccharide-stimulated peritoneal macrophages.

Authors:  Rafael Simone Saia; Fabíola Leslie Mestriner; Giuliana Bertozi; Fernando Queiróz Cunha; Evelin Capellari Cárnio
Journal:  Mediators Inflamm       Date:  2014-07-13       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.